(Cetrelimab)Biosimilar Reference Antibody-GS40128

货号：GS40128

Cetrelimab is an investigational fully human monoclonal antibody developed as an immune checkpoint inhibitor for the treatment of various cancers. It functions by blocking a key receptor on immune cells to restore anti-tumor immune activity. Clinical trials have evaluated its efficacy, both as a monotherapy and in combination with other agents (such as targeted therapies or chemotherapy), in multiple tumor types including prostate cancer, renal cell carcinoma, and solid tumors with specific genetic alterations.